Consistent with results from a study showing that deletion of CD33 results in an inflammatory human microglial phenotype [63], our results suggest that a high CRP level together with the rs3865444(C) risk allele increases CD33 expression in the brain and, by extension, neuroinflammation, leading to hallmark AD pathology. The gene discussed is CD33; the disease is Alzheimer disease.